Detalhe da pesquisa
1.
Risk Factors for Lenvatinib-Induced High-Grade Hypothyroidism in Patients with Hepatocellular Carcinoma: A Retrospective Study.
Pharmacology
; 108(5): 460-468, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591220